Skip to content

Original Research

Frontiers in Oncology ·

Volume 16 - 2026 | https://doi.org/10.3389/fonc.2026.1915743

Barriers and facilitators to symptom-related help-seeking among men with genitourinary malignancies: a qualitative study

  • Rong Liu1
  • Xiang Xi1*corresponding author
  • Xiao Ma1
  • Yu Zhao1
  • Hui Zhuo1
  1. Chengdu Third People’s Hospital, Chengdu, China
Article metrics0 viewsView details

Abstract

To explore perceived barriers and facilitating factors related to symptom-related help-seeking among men with genitourinary malignancies and inform the development of symptom-management support. Men with genitourinary malignancies were recruited through purposive sampling at a tertiary hospital. Data were collected through semi-structured, in-depth interviews and analyzed using Colaizzi’s seven-step method. Fifteen men were interviewed, and two themes with five subthemes were identified. Barrier factors comprised limited symptom knowledge, psychosocial concerns, and difficulties accessing information and symptom-management support. Facilitating factors comprised social and family support and perceived benefits of seeking professional help. The findings suggest potential priorities for symptom-management support, including symptom education, family and social support, and accessible professional advice. Their relevance should be considered in relation to the cancer types, age distribution, and care setting represented in this study.

Keywords

Introduction

Male genitourinary malignancies include cancers of the kidney, prostate, bladder, testis, ureter, and penis (1–4). Cancer statistics in the United States indicate that the highest prevalence of cancer in men is prostate cancer, followed by bladder, kidney, and testicular cancer (5, 6). The increase in its incidence may be related to factors such as population aging, modern lifestyle changes, increased exposure to risk factors, advances in disease screening and diagnosis, and improved residents’ awareness of self-protection (7). Early cancer diagnosis and treatment are key to effective and efficient care, and one factor associated with timely access to treatment is seeking medical help for potential cancer symptoms (8, 9).

Symptom-related help-seeking refers to decisions about seeking medical help and using healthcare services after noticing a potential cancer symptom. Factors discussed in the literature include age, marital status, educational level, family history of cancer, fear of cancer, perceived threat, and disclosure of symptoms to significant others. In the Chinese cultural context, expectations concerning men’s family and social roles may shape their experiences of illness (10). For cancers involving the urinary tract or male reproductive organs, concerns about intimate symptoms and sexual function may make it difficult for men to seek medical help and discuss their needs (11).

Research has examined help-seeking before cancer diagnosis, but further work is needed to understand how men with different genitourinary malignancies describe help-seeking across diagnosis and treatment (12, 13). The Health Belief Model (HBM) offers concepts for interpreting perceived threat, benefits, barriers, cues to action, and self-efficacy in health behavior (14, 15). Its relevance to the present findings is considered in the Discussion.

This descriptive phenomenological study explored men’s experiences of symptom-related help-seeking in the context of genitourinary malignancies. It aimed to identify perceived barriers and facilitators and inform priorities for nursing support.

Methods

Informants

From July to December 2025, men with genitourinary malignancies who returned for treatment at the Department of Urology, the Third People’s Hospital of Chengdu, China, were recruited through purposive sampling. The stated inclusion criteria were male sex, age ≥18 years, a genitourinary malignancy, receipt of surgery, radiotherapy, or chemotherapy at the hospital, awareness of the diagnosis, and willingness to participate. The stated exclusion criteria were severe mental illness, cognitive impairment, communication difficulties, other cancers, or participation in similar studies. Fifteen informants were included. No new themes were reported during analysis of the overall interview material (16); this does not establish data adequacy within individual cancer types or age groups. The study was approved by the Ethics Committee of the Third People’s Hospital of Chengdu (No. 2025-S-3).

Development of the interview guide

The research team developed a semi-structured interview guide based on the literature and clinical experience. Pilot interviews were conducted with one informant with bladder cancer and one with prostate cancer. The team refined the guide using feedback from these informants and six experts: three chief physicians in urological oncology, two clinical nursing experts, and one psychologist. The interviewer clarified questions when informants had difficulty understanding them. The nine questions are presented in the interview guide below (see Table 1).

Table 1. Interview outline.

Interview guide
1. From the time of diagnosis to the present, what symptoms have you noticed that you associate with your genitourinary cancer?
2. How do you perceive these symptoms?
3. What aspects of these symptoms concern you?
4. How have you responded to these symptoms or sought help?
5. What difficulties have you encountered?
6. What factors have hindered or facilitated your help-seeking for symptoms related to genitourinary cancer?
7. What other needs do you have regarding symptom-related help-seeking and symptom management?
8. What kind of help would you like?9. Is there anything else you would like to add?

Data collection and quality control methods

Individual interviews were conducted in a quiet consultation room, with only the interviewer and informant present, and lasted 60–90 minutes. The interviewer was a nursing team leader with clinical experience in caring for men with genitourinary malignancies. Before each interview, the study purpose and procedures were explained, confidentiality was discussed, and written informed consent was obtained. Interviews were audio-recorded, and field notes documented facial expressions, body movements, and recurrent expressions. Recordings were transcribed and checked with the informants for accuracy.

Data analysis methods

Interview data were analyzed using Colaizzi’s method (17). Recordings were transcribed after the interviews and checked against field notes. Team members trained in qualitative research, including a nursing graduate student, repeatedly read the transcripts and identified statements relevant to symptom-related help-seeking. Two analysts developed preliminary interpretations of these statements and formulated meaning units. NVivo was used to organize the coded material. Differences in coding and theme development were discussed within the research team. Transcripts were checked with informants for accuracy.

Results

Fifteen informants, identified as I1–I15, were aged 28–81 years(61.73 ± 14.58). Table 2 summarizes their characteristics. The sample included four informants with bladder cancer, four with prostate cancer, three with kidney cancer, two with penile cancer, and two with testicular cancer. Eleven informants were married, three were widowed, and one was unmarried. Two themes and five subthemes were identified (Table 3).

Table 2. General information of the study subjects.

Informant numberAgeMarital statusEducational levelEmployment statusPlace of residenceType of tumorTumor clinical stagingTreatment
I128UnmarriedJunior high school and belowEmployedUrbanPenile cancerStage ISurgical treatment
I266MarriedHigh schoolUnemployedRuralBladder cancerStage IIISurgical treatment
I353MarriedHigh schoolUnemployedUrbanKidney cancerStage IVTargeted therapy combined with immunotherapy
I438MarriedCollege or aboveEmployedUrbanTesticular cancerStage IISurgical treatment
I552MarriedHigh schoolEmployedUrbanKidney cancerStage IIITargeted Therapy
I664MarriedCollege or aboveRetiredUrbanBladder cancerStage IISurgical treatment
I781WidowedJunior high school and belowRetiredRuralProstate cancerStage IIISurgical treatment
I874MarriedCollege or aboveRetiredUrbanProstate cancerStage IISurgical treatment
I967MarriedCollege or aboveRetiredUrbanProstate cancerStage IISurgical treatment
I1067WidowedCollege or aboveRetiredUrbanBladder cancerStage IISurgical treatment
I1167MarriedJunior high school and belowRetiredRuralKidney cancerStage IIISurgical treatment
I1275MarriedJunior high school and belowUnemployedRuralProstate cancerStage IVTargeted Therapy
I1375WidowedJunior high school and belowUnemployedUrbanBladder cancerStage IVTargeted therapy combined with immunotherapy
I1452MarriedHigh schoolEmployedUrbanPenile cancerStage IIISurgical treatment
I1567MarriedJunior high school and belowRetiredRuralTesticular cancerStage IVTargeted Therapy

Table 3. Themes, subthemes, and categories.

ThemesSubthemesCategories
Barrier factorsLimited symptom knowledge and risk awarenessMild symptoms and benign explanations
Trivialization of symptoms
Psychosocial barriers to symptom-related help-seekingSexual function concerns and stigma
Negative emotions and symptom concealment
Family responsibilities and gender role expectations
Limited access to information and symptom-management support—
Facilitating factorsSocial and family support for symptom-related help-seeking—
Perceived benefits of seeking professional help—

Theme 1: barrier factors

Subtheme 1: limited symptom knowledge and risk awareness

This subtheme describes how informants interpreted symptoms and judged whether medical attention was needed. Their accounts reflected two patterns: attributing symptoms to benign causes and minimizing the importance of symptoms.

Mild symptoms and benign explanations

Informants attributed symptoms to gastrointestinal problems, prostatic enlargement, or reduced immunity. These explanations appeared to make the symptoms less concerning and reduced their perceived need for assessment.

I2: “Before I was diagnosed, I had a dull pain in my lower abdomen, but I thought it was a gastrointestinal problem. The pain was not very noticeable, so I thought it was nothing to worry about.”

I3: “I had been going to the toilet frequently. At night, I had to get up about five or six times. I thought there was something wrong with my bladder or kidneys; I did not know it was cancer.”

I10: “I often get up at night to go to the toilet, and I feel that I have not finished urinating. I think it is an enlarged prostate, so I buy medicine and take it myself.”

I4: “Since last year, I have often had colds and fevers, and I have been losing weight. I thought my immune system had become weaker.”

Trivialization of symptoms

Informants described symptoms as familiar, mild, or insufficiently disruptive to warrant medical attention. Some interpreted urinary changes as part of aging, whereas others focused on another health problem. These accounts suggest that noticing a bodily change did not necessarily lead to recognizing a need for further assessment.

I1: “What did I know about cancer symptoms? I thought frequent urination and pain when urinating were normal as you got older.”

I2: “I noticed changes in my urination, but I thought they were minor because they happened almost every day and did not seriously affect my life.”

I9: “I had been healthy, but later I found out that my blood pressure was high. I was treated for high blood pressure, and a mass was found during a medical examination.”

Subtheme 2: psychosocial barriers to symptom-related help-seeking

Sexual function concerns and stigma

This subtheme concerns emotional and social pressures that made symptom disclosure or help-seeking difficult. Informants described embarrassment about sexual concerns, fears about treatment and illness, and tensions between seeking care and fulfilling family or masculine roles. The following accounts illustrate concerns about sexual function and anticipated judgment by others.

I11: “I’m embarrassed to say that I have a problem with that (bladder); people may think that I did not go out to have sex before. As a man, people will laugh at me if I lose my basic male function…” I4: “The doctor told me that the operation would involve removing part of the gland. I am afraid this will affect my sexual function and our sex life as a couple. I also feel embarrassed discussing sex with the healthcare staff, my family, or my friends.”

I14: “It has been a long time since the operation, but I still do not dare to look at my penis. Part of it was removed. I feel that I have lost part of what makes me a man. I am afraid that the operation may not have cured the disease. What is the point of being a man now? I feel as though I can no longer hold my head up.”

Negative emotions and symptom concealment

Informants described fear, discouragement, and reluctance to discuss illness or symptoms. Some concealed symptoms to avoid worrying family members, whereas others doubted whether professionals could help or were reluctant to undergo further treatment. These accounts illustrate different reasons for withholding concerns rather than a single emotional response shared by all informants.

I14: “When I noticed that my urine was red, I felt frightened and panicked. I did not tell my family or friends because I did not want them to feel the same distress. I monitored my symptoms and bought medicine myself. After several days without improvement, I went to hospital.”

I6: “I do not think there is anything more the doctors can do. They are doing everything they can. I do not have much confidence; I will die sooner or later.”

I5: “I’m scared. Because I don’t go very often, I don’t like to talk about things…… Because a year ago, a few years ago, I had a lot of surgery, and I just didn’t want to do it again.”

I2: “I noticed changes in my body at first, but I could not find anyone to talk to. When I was diagnosed, I tried to forget that I had cancer. I wanted to act as though it did not exist and avoid conversations about cancer. I wanted my life to go back to how it was before.”

I15: “I thought the symptoms were minor. Going to the doctor or nurse every day might bother them because they were already busy. Going to hospital every day also put a strain on my family and made me feel increasingly useless.”

Family responsibilities and gender role expectations

This category describes tensions between seeking care and meeting work, family, or gender-related expectations. Some informants prioritized work or feared that taking leave would threaten their ability to support their families. Others felt that enduring symptoms was preferable to being judged as making a fuss.

I15: “At first, I did not think it was very serious. Treatment is uncomfortable, so I thought I should not worry about every small problem. I was afraid people would think I was making a fuss or talk about me behind my back. I thought the symptoms would go away after a while and that I could cope with them.”

I7: “I know I have symptoms, but I am too busy with work to see a doctor. I have to finish my work before I can think about my health.”

I4: “I have older family members and children to support. Taking too much medical leave will affect my work. If I lose my job because of this illness and these symptoms, what will my family do?”

Subtheme 3: limited access to information and symptom-management support

Due to limited knowledge of the disease and limited resources for home rehabilitation, most patients hoped to learn more about the disease from medical staff, clarify disease progression, and understand subsequent treatment and follow-up plans. Their accounts suggested that information needs were not always met during clinical encounters. Informants also wanted supportive communication and professional guidance on rehabilitation and symptom management.

I8: “I want the doctor to explain my illness and treatment clearly. The hospital is far from my home. If I develop symptoms after going home, I hope I can contact doctors or nurses online for professional advice.”

I9: “The internet is becoming more widely used, but it is still difficult for older people like me. I have a stoma on my abdomen, but I struggle to care for it and change the bag myself. I wish the hospital and community health center offered regular education and professional help.”

I11: “I know cancer is difficult to cure, but I have also had side effects during treatment and have been to hospital several times this year. I wish the staff had explained the treatment, its side effects, and what to look out for before treatment started.”

Theme 2: facilitating factors

Subtheme 1: social and family support for symptom-related help-seeking

This subtheme describes how family members, healthcare staff, and other patients supported symptom disclosure and engagement with care. Family encouragement prompted one informant to seek assessment, while reassurance and practical encouragement helped another cope after surgery. These examples relate to different points in the care trajectory.

I13: “My urine was red for several days. I was terrified and told my family. They insisted that I go to the hospital to have it checked.”

I7: “In the first few days after surgery, I felt low. My wound was very painful, and I had severe abdominal bloating. I felt anxious and sometimes cried privately. I appreciated my wife, the healthcare staff, and other patients encouraging me to relax and get out of bed. As my condition improved, I became more willing to engage with treatment. I am now about to be discharged. The doctor advised regular follow-up, and I plan to monitor changes in my body.”

Subtheme 2: perceived benefits of seeking professional help

This subtheme describes how informants experienced professional advice as useful and reassuring. Access to information and responsive communication made support valuable during symptom management. The accounts show perceived benefits of seeking help, but do not establish that these experiences changed later help-seeking behavior.

I8: “I joined the department’s WeChat group after discharge, and the staff regularly shared information about the disease. I felt it was very useful. When I encountered problems with the symptoms, I would also ask related questions in the group, and the medical staff would patiently answer my questions.”

I13: “After the catheter was removed, I could not pass urine and my abdomen became very swollen, so it was put back in. I was terrified that it would never be removed. I am grateful that the staff explained what had happened, listened to my concerns, and helped me prepare for catheter removal. That made me less afraid. The catheter was eventually removed successfully.”

Discussion

This study identified individual, interpersonal, and service-related considerations in symptom-related help-seeking among 15 men with genitourinary malignancies. The accounts suggest that recognizing a symptom, feeling able to disclose it, and obtaining professional advice are related but distinct challenges. They also span prediagnostic symptom appraisal and symptom management during treatment. The contribution is therefore an account of perceived needs across these experiences, rather than evidence of a uniform pathway shared by all cancer types.

Symptom recognition did not necessarily translate into a perceived need for assessment. Emotional responses may also shape how people interpret symptoms and decide when to seek medical advice (18). Previous research has described limited cancer knowledge, non-specific symptoms, inaccurate symptom attribution, and symptom trivialization as barriers to help-seeking (19–21). Informants sometimes explained symptoms as benign or considered them too minor to warrant attention. A UK qualitative study of cancer alarm symptoms similarly described normalization and concern about wasting clinicians’ time (8). Research in men with possible prostate cancer also identified symptom misinterpretation and the role of social contacts in decisions to seek help (22). These comparisons suggest that education should address how symptoms are interpreted, alongside providing cancer information. In practice, a candidate approach is to explain which persistent or changing symptoms merit discussion and whom to contact, while avoiding the implication that every urinary symptom indicates cancer. The present interviews did not test whether such education would change behavior.

Sexual concerns, anticipated judgment, and responsibilities to others appeared to make disclosure difficult for some informants (23). Previous research has shown that embarrassment, fear of illness and treatment, and expectations of the male role are barriers to help seeking (12, 24–26). The present accounts suggest that these concerns can coexist with practical pressures, such as work and family obligations, rather than operate independently. Similar interactions across personal, interpersonal, and institutional levels were described in a Nigerian prostate cancer study (21). Private opportunities to discuss urinary and sexual concerns may therefore be useful, with clinicians asking about the patient’s own priorities rather than assuming that all men endorse the same gender expectations. This is a proposed implication of the findings, not evidence that a particular communication intervention is effective.

When support is difficult to access, patients may try to manage symptoms themselves, particularly in settings with limited resources (13). Previous qualitative research has highlighted the relevance of social context to symptom appraisal and help-seeking (27, 28). Difficulties obtaining information were linked to uncertainty about post-discharge support. The contrast between requests for online advice and difficulties using digital services suggests that access depends on usability as well as availability. Previous studies have also described the information needs of patients and the importance of community support (29). Because that study involved women with different cancers, it offers contextual comparison rather than direct confirmation of the present findings. For this sample, options worth evaluating include a named contact for symptom questions, clear explanations of follow-up arrangements, and telephone or face-to-face alternatives to online communication. The interviews do not establish the effectiveness of these options or justify conclusions about the quality of the Chinese healthcare system as a whole.

A qualitative study of kidney cancer screening intentions identified low perceived risk, time constraints, and limited information as barriers, alongside social support and professional recommendations (30). Social support had more than one potential role. Family encouragement helped one informant seek assessment, yet other accounts described concealing symptoms to avoid worrying relatives or jeopardizing family responsibilities. Chinese research on help-seeking in ovarian cancer likewise identified caregiver availability, role demands, and practical burdens (31). Thus, the presence of family members should not be treated as equivalent to supportive involvement. Asking whom a patient wishes to involve, and what help that person can provide, may be more informative than marital status alone. The present data cannot determine whether married, unmarried, or widowed men experienced systematically different barriers; such comparisons would require more detailed contextual data and adequate representation.

Informants valued clear explanations, responsive advice, and reassurance during symptom management. As an interpretive lens, the HBM links symptom minimization with perceived threat, anticipated embarrassment and practical difficulty with perceived barriers, and useful advice with perceived benefits. Family encouragement may be understood as a cue to action. This mapping is an interpretation of the accounts, not a test of the model; self-efficacy and changes in later help-seeking were not established. Future longitudinal interviews could explore whether helpful encounters strengthen confidence in seeking advice and how this varies across stages of care.

Summary

This study explored perceived barriers and facilitating factors in symptom-related help-seeking among men with genitourinary malignancies. The findings suggest that symptom-management support should consider social and cultural contexts, gender role expectations, and psychological concerns. Potential priorities include accessible professional advice and support that addresses patients’ family circumstances and perceived needs.

Several limitations should be acknowledged. The small sample included only two to four informants per cancer type, limiting exploration of tumor-specific barriers and facilitating factors. Although no new themes were reported during analysis of the overall sample, this does not establish saturation within each cancer type or age group. The findings should not be assumed to apply uniformly across cancer types or age groups. Recruitment from a single tertiary hospital further limits transferability to other settings and cultural contexts, and retrospective accounts across varying disease courses may be affected by recall bias. Family history of cancer was not systematically collected, limiting our ability to explore how these characteristics shaped symptom-related help-seeking. Future multicenter qualitative studies should recruit more informants within individual cancer types and across age groups to explore shared and distinct experiences. Longitudinal interviews could examine changes in help-seeking across treatment stages.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Footnotes

Edited by: Surya P Singh, University of Oklahoma Health Sciences Center, United States

Reviewed by: Arsen Davitadze, ITMO University, Russia

Juan Guillermo Cataño Cataño, Puntificia Universidad Javeriana, Colombia

Statements

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

The author(s) declared that financial support was not received for this work and/or its publication.

Data availability

The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.

Ethics approval

The studies involving humans were approved by Ethics Committee of Chengdu Third People’s Hospital. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

RL: Writing – review & editing, Visualization, Writing – original draft, Methodology, Conceptualization. XX: Supervision, Writing – review & editing, Formal analysis, Conceptualization. XM: Visualization, Formal analysis, Writing – review & editing. YZ: Writing – review & editing, Visualization. HZ: Writing – review & editing, Supervision, Conceptualization.

References

  1. 1 Montironi R, Cimadamore A. Tumors of the urinary system and male genital organs: 2022 World Health Organization classification and multidisciplinarity. Eur Urol. (2022) 82: 483–6. doi: doi:10.1016/j.eururo.2022.07.032
  2. 2 Tian YQ, Yang JC, Hu JJ, Ding R, Ye DW, Shang JW. Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the Global Burden of Disease Study 2019. Front Public Health. (2023) 11: 1119374. doi: doi:10.3389/fpubh.2023.1119374
  3. 3 Sasaki T, Higashi T, Inoue T. Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan. Int J Clin Oncol. (2024) 29: 1088–95. doi: doi:10.1007/s10147-024-02575-3
  4. 4 Leung DKW, Wong CHM, Ko ICH, Siu BWH, Liu AQY, Meng HYH. Global trends in the incidence, mortality, and risk-attributable deaths for prostate, bladder, and kidney cancers: A systematic analysis from the Global Burden of Disease Study 2021. Eur Urol Oncol. (2025) 8: 1533–43. doi: doi:10.1016/j.euo.2025.05.007
  5. 5 Ghazwani Y, Alghafees M, Suheb MK, Shafqat A, Sabbah BN, Arabi TZ. Trends in genitourinary cancer mortality in the United States: Analysis of the CDC-WONDER database 1999–2020. Front Public Health. (2024) 12: 1354663. doi: doi:10.3389/fpubh.2024.1354663
  6. 6 Schafer EJ, Jemal A, Wiese D, Sung H, Kratzer TB, Islami F. Disparities and trends in genitourinary cancer incidence and mortality in the USA. Eur Urol. (2023) 84: 117–26. doi: doi:10.1016/j.eururo.2022.11.023
  7. 7 Li W, Liang H, Wang W, Liu J, Liu X, Lao S. Global cancer statistics for adolescents and young adults: Population based study. J Hematol Oncol. (2024) 17: 99. doi: doi:10.1186/s13045-024-01623-9
  8. 8 Whitaker KL, Macleod U, Winstanley K, Scott SE, Wardle J. Help seeking for cancer “alarm” symptoms: A qualitative interview study of primary care patients in the UK. Br J Gen Pract. (2015) 65: e96 – e105. doi: doi:10.3399/bjgp15X683533
  9. 9 Sun D, Li H, Cao M, He S, Lei L, Peng J. Cancer burden in China: Trends, risk factors and prevention. Cancer Biol Med. (2020) 17: 879–95. doi: doi:10.20892/j.issn.2095-3941.2020.0387
  10. 10 McIntosh S, Harries B, Perry M, Cropley M, Dibb B. Barriers & facilitators to help-seeking behaviour for abnormal lower urinary tract symptoms in men: Systematic review. Cancer Med. (2025) 14: e71214. doi: doi:10.1002/cam4.71214
  11. 11 Smith GD, Hebdon M. Mental health help-seeking behaviour in men. J Adv Nurs. (2024) 80: 851–3. doi: doi:10.1111/jan.15869
  12. 12 Medina-Perucha L, Yousaf O, Hunter MS, Grunfeld EA. Barriers to medical help-seeking among older men with prostate cancer. J Psychosoc Oncol. (2017) 35: 531–43. doi: doi:10.1080/07347332.2017.1312661
  13. 13 McCutchan G, Weiss B, Quinn-Scoggins H, Dao A, Downs T, Deng Y. Psychosocial influences on help-seeking behaviour for cancer in low-income and lower middle-income countries: A mixed-methods systematic review. BMJ Global Health. (2021) 6: e004213. doi: doi:10.1136/bmjgh-2020-004213
  14. 14 Maseko TN, Huang HC, Lin KC. Cervical cancer screening behavior of African women: The Rosenstock health belief model assessment. Health Care Women Int. (2021) 42: 976–91. doi: doi:10.1080/07399332.2019.1677665
  15. 15 Zeng Q, Chen W, Xu S, Yang X, Xue D, Peng Y. Understanding facilitators and barriers to adherence in home-based pulmonary rehabilitation for chronic obstructive pulmonary disease patients using the Health Belief Model: A qualitative study. Front Public Health. (2025) 13: 1553744. doi: doi:10.3389/fpubh.2025.1553744
  16. 16 Moura C, Silva ÍR, Silva T, Santos KA, Crespo MC, Silva M. Methodological path to reach the degree of saturation in qualitative research: Grounded theory. Rev Bras Enferm. (2021) 75: e20201379. doi: doi:10.1590/0034-7167-2020-1379
  17. 17 Vignato J, Inman M, Patsais M, Conley V. Computer-assisted qualitative data analysis software, phenomenology, and Colaizzi’s method. West J Nurs Res. (2022) 44: 1117–23. doi: doi:10.1177/01939459211030335
  18. 18 Balasooriya-Smeekens C, Walter FM, Scott S. The role of emotions in time to presentation for symptoms suggestive of cancer: A systematic literature review of quantitative studies. Psychooncology. (2015) 24: 1594–604. doi: doi:10.1002/pon.3833
  19. 19 Schliemann D, Ismail R, Donnelly M, Cardwell CR, Su TT. Cancer symptom and risk factor awareness in Malaysia: Findings from a nationwide cross-sectional study. BMC Public Health. (2020) 20: 464. doi: doi:10.1186/s12889-020-08581-0
  20. 20 Üzümçeker E. Traditional masculinity and men’s psychological help-seeking: A meta-analysis. Int J Psychol. (2025) 60: e70031. doi: doi:10.1002/ijop.70031
  21. 21 Ezenwankwo EF, Oladoyimbo CA, Dogo HM, Idowu AA, Alabi AO, Oyelekan A. Factors influencing help-seeking behavior in men with symptoms of prostate cancer: A qualitative study using an ecological perspective. Cancer Invest. (2021) 39: 529–38. doi: doi:10.1080/07357907.2021.1933009
  22. 22 Shaw B, Walter FM, Hamilton W, Martins T. Symptom appraisal and help seeking in males with symptoms of possible prostate cancer: A qualitative study with an ethnically diverse sample in London. Br J Gen Pract. (2023) 73: e502–10. doi: doi:10.3399/BJGP.2022.0554
  23. 23 Sethi R, Rodin G, Hales S. Psychotherapeutic approach for advanced illness: Managing cancer and living meaningfully (CALM) therapy. Am J Psychother. (2020) 73: 119–24. doi: doi:10.1176/appi.psychotherapy.20190050
  24. 24 Fish JA, Prichard I, Ettridge K, Grunfeld EA, Wilson C. Psychosocial factors that influence men’s help-seeking for cancer symptoms: A systematic synthesis of mixed methods research. Psychooncology. (2015) 24: 1222–32. doi: doi:10.1002/pon.3912
  25. 25 Rubach A, Balasubramaniam K, Elnegaard S, Larsen SE, Jarbøl DE. Barriers to health care seeking with bothersome lower urinary tract symptoms among men-a nationwide study. Fam Pract. (2019) 36: 743–50. doi: doi:10.1093/fampra/cmz019
  26. 26 Mokhwelepa LW, Sumbane GO. Men’s mental health matters: The impact of traditional masculinity norms on men’s willingness to seek mental health support; a systematic review of literature. Am J Mens Health. (2025) 19: 15579883251321670. doi: doi:10.1177/15579883251321670
  27. 27 Adam R, Thornton AJ, Whitaker KL, Murchie P, Hannaford PC, Hall S. How does social context influence appraisal and help‐seeking for potential cancer symptoms in adults aged 50 and over? A qualitative interview study. Eur J Cancer Care. (2022) 31: e13640. doi: doi:10.1111/ecc.13640
  28. 28 Saldaña-Téllez M, Meneses-Navarro S, Cano-Garduño L, Unger-Saldaña K. Barriers and facilitators for breast cancer early diagnosis in an indigenous community in Mexico: Voices of otomí women. BMC Womens Health. (2024) 24: 33. doi: doi:10.1186/s12905-023-02875-2
  29. 29 Chai KC, Zhang YB, Chang KC. Regional disparity of medical resources and its effect on mortality rates in China. Front Public Health. (2020) 8: 8. doi: doi:10.3389/fpubh.2020.00008
  30. 30 Ma X, Liu R, Zhuo H, Xi X. Patients’ knowledge, attitudes, preferences regarding kidney cancer screening, and factors influencing participation intentions: A qualitative study. Front Oncol. (2026) 16: 1699073. doi: doi:10.3389/fonc.2026.1699073
  31. 31 Yin H, Zha Y, Zhou Y, Tao H, Zhu D. What are the barriers and facilitators to help-seeking behaviour for symptoms in patients with ovarian cancer in China? A qualitative study. BMJ Open. (2024) 14: e087602. doi: doi:10.1136/bmjopen-2024-087602

Citation

Liu, R., et al. (2026). Barriers and facilitators to symptom-related help-seeking among men with genitourinary malignancies: a qualitative study. Frontiers in Oncology, Volume 16. https://doi.org/
Received
Accepted
Published
Volume
16 - 2026

Copyright

Copyright © 2026 Liu, Xi, Ma, Zhao and Zhuo.

License: https://creativecommons.org/licenses/by/4.0/

*Correspondence: Xiang Xi

Article metrics

Views
0
Downloads
0
Citations
0
Shares
0